Nanthealth, Inc.

NHIQCIK 0001566469 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed May 1, 2023. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0013

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Feb 8, 2024no items parsed Jan 2, 2024no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Nanthealth, Inc.

Name	Roles	Filings
Blaszyk Michael D	Director	1
Calhoun Kirk K	Director	1
California Capital Equity, LLC	10% Owner	1
Nant Capital, LLC	10% Owner	1
Nantworks, LLC	10% Owner	1

Showing 1-5 of 8

Per pagePage 1 of 2Next

All filings

5 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Sep 19, 2023	Naseem Rao Haris Chief Executive Officer · Director · 10% Owner	Holdings only	-	-	-
Aug 30, 2023	Soon-Shiong Patrick Chief Executive Officer · Director · 10% Owner	PPurchase	537,272	$18.6125	$9,999,975
Jun 10, 2022	Wise Deanna L. Director	Holdings only	-	-	-
Jun 10, 2022	Calhoun Kirk K Director	Holdings only	-	-	-
Jun 10, 2022	Blaszyk Michael D Director	Holdings only	-	-	-

Showing 1-5 of 5

Per pagePage 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value